GlassScriptPhysician profile
Nathan D Peffer
NPI 1003296567
$5,731.74
in general payments reported to CMS, 2019-2025
40 companies · $543 in 2025
The $543 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $183 · 2021: $1,038 · 2022: $1,010 · 2023: $1,423 · 2024: $1,359 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,325.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,857.77 | 2021-2025 | Interstim, Biosyn |
| Teleflex LLC | $506.22 | 2021-2024 | Urolift |
| Astellas Pharma US INC | $457.22 | 2020-2025 | Xtandi |
| Abbvie INC. | $453.29 | 2020-2025 | |
| Boston Scientific Corporation | $297.77 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml |
| Bayer Healthcare Pharmaceuticals INC. | $231.40 | 2023 | |
| 180 Medical, INC. | $153.20 | 2021-2022 | |
| Olympus America INC. | $125.22 | 2022-2025 | Itind System |
| Allergan, INC. | $121.46 | 2021-2022 | |
| Travere Therapeutics, INC. | $120.68 | 2019 | |
| Sumitomo Pharma America, INC. | $89.82 | 2023-2024 | Orgovyx, Gemtesa |
| Progenics Pharmaceuticals, INC. | $87.74 | 2021-2024 | Pylarify |
| Blue Earth Diagnostics | $80.88 | 2023-2024 | |
| Coloplast Corp | $80.84 | 2021-2025 | |
| Myovant Sciences INC. | $79.41 | 2021-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $78.54 | 2024 | |
| Merck Sharp & Dohme LLC | $72.98 | 2022-2024 | Keytruda, Lynparza |
| Hollister Incorporated | $58.30 | 2022-2023 | Vapro Pocket |
| Laborie Medical Technologies Corp. | $51.36 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Mission Pharmacal Company | $49.35 | 2022-2024 | Uribel, Uribel Tabs |
| C. R. Bard, INC. & Subsidiaries | $49.23 | 2022-2024 | Bard Urinary Drainage Bag |
| Pfizer INC. | $48.82 | 2022 | |
| Dentsply Ih Ab | $46.73 | 2023 | Lofric |
| Endo Pharmaceuticals INC. | $44.63 | 2020-2022 | |
| Axonics, INC. | $43.59 | 2024 | Axonics, Bulkamid |
| Smith+Nephew, INC. | $42.96 | 2025 | Grafix Pl, Stravix, Oasis |
| Telix Pharmaceuticals | $41.00 | 2022-2023 | Illuccix |
| Photocure INC | $40.05 | 2023-2024 | Cysview |
| Convatec INC. | $39.72 | 2023 | |
| Procept Biorobotics Corporation | $38.52 | 2023 | Aquabeam Robotic System |
| Tolmar, INC. | $37.57 | 2023-2024 | |
| Myriad Genetic Laboratories, INC. | $34.71 | 2024 | Prolaris |
| Baxter Healthcare | $30.38 | 2024 | Perclot |
| Dendreon Pharmaceuticals LLC | $27.30 | 2021 | |
| Endo USA, INC. | $21.73 | 2024 | Xiaflex |
| Trevena, INC. | $21.54 | 2021 | |
| Janssen Biotech, INC. | $19.79 | 2025 | Erleada |
| Tolmar Pharmaceuticals, INC. | $18.20 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.02 | 2022 | |
| Immunitybio, INC. | $13.80 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Peffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.